Indications
This medicinal product is for diagnostic use only. Radiolabelled Lymphoseek is indicated for imaging and intraoperative detection of sentinel lymph nodes draining a primary tumour in adult patients with breast cancer, melanoma, or localised squamous cell carcinoma of the oral cavity. External imaging and intraoperative evaluation may be performed using a gamma detection device.
Composition
- Active substance
- tilmanocept
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Lymphoseek
- Active substance
- tilmanocept
- ATC code
- V09IA09
- Group
- Various
- Therapeutic area
- Radionuclide Imaging
- Marketing authorisation holder
- Navidea Biopharmaceuticals Europe Ltd.